(Q34158420)

31 July 2017

1 reference

title

Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis (English)

1 reference

31 July 2017

0 references

1 reference

van Roon JA

1

1 reference

PubMed ID

11212172

31 July 2017

Lafeber FP

series ordinal

2

1 reference

PubMed ID

11212172

31 July 2017

Bijlsma JW

series ordinal

3

1 reference

31 July 2017

1 January 2001

1 reference

31 July 2017

Arthritis & Rheumatology

1 reference

31 July 2017

44

1 reference

31 July 2017

1

1 reference

31 July 2017

3-12

1 reference

Rheumatoid arthritis. Pathophysiology and implications for therapy

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

New roles for rheumatoid factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Do self-perpetuating B lymphocytes drive human autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

A proinflammatory role for IL-18 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Divergent T-cell cytokine patterns in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Th1/Th2 cytokine balance in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Receptors for immunoglobulin G. Molecular diversity and implications for disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Degradation of human articular cartilage by neutrophils in synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Suppressive effect of interleukin-4 (IL-4) on IL-6 production by adherent rheumatoid synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-8 secretion and 15-lipoxygenase activity in rheumatoid arthritis: in vitro anti-inflammatory effects by interleukin-4 and interleukin-10, but not by interleukin-1 receptor antagonist protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Terminal differentiation of spontaneous rheumatoid factor-secreting B cells from rheumatoid arthritis patients depends on endogenous interleukin-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

IL-10 and IL-4 synergize with TNF-α to induce IL-1ra production by human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Effect of interleukin-10 on dendritic cell maturation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C3%3A%3AAID-ANR2%3E3.0.CO%3B2-U

10.1002/1529-0131(200101)44:1<3::AID-ANR2>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11212172